ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000267118.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.026071405	Sensitive
ENSG00000267118.1	ABT-263 (navitoclax)	Esophageal cancer	0.045835558	Sensitive